BioSpace News Archive

Emmes announced that three corporate vice presidents have been promoted. Dr. Traci Clemons has been named chief research officer, Marian Ewell is now chief scientific innovation officer, and Jennifer Hester is the company’s chief human resources officer.

La Jolla Pharmaceutical Company (Nasdaq: LJPC), which is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases, today announced financial results for the three and six months ended June 30, 2020 and highlighted recent corporate progress. Recent Corporate Progress Acquisition of Tetraphase Pharmaceuticals, Inc.: On July 28, 2020, La

Record Quarter for Consumer Brands with 3X Revenue Growth Lowest Cash Operating Expenses in Five Quarters $200 Million Private Placement Significantly Reduced Debt and Debt Servicing Expense [06-August-2020] EMERYVILLE, Calif. , Aug. 6, 2020 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and B

Viveve Medical, Inc., a medical technology company focused on women’s intimate health, announced that it will report its second quarter 2020 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, August 13, 2020.

The Alliance for Regenerative Medicine announces the publication of its H1 2020 Global Sector Report, “Innovation in the Time of COVID-19.” The report provides an in-depth look at trends and metrics in the gene, cell, and tissue-based therapeutic sector in the midst of the pandemic.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced updates related to the company’s commitment to the amyotrophic lateral sclerosis (ALS) community, in celebration of the third anniversary of the U.S. availability of RADICAVA ® (edaravone).

Yulong Eco-Materials Limited announced that it has changed its name to EV Biologics, Inc.

AV-101 is a Proprietary Inhaled Version of Imatinib, Which Has Proven Efficacy Treating PAH; Aerovate Was Founded and Seeded by RA Capital Management; Series A is Led by Sofinnova Investments; Includes New Investors Atlas Venture, Cormorant Asset Management, Surveyor Capital and Osage University Partners

Esteemed molecular pathologist to accelerate the use of real-world data for life sciences and health systems product and service development

Lankenau Heart Institute, part of Main Line Health, has named Basel Ramlawi, MD, the System Chief of Cardiac Surgery for Main Line Health and co-director of the Lankenau Heart Institute.